Evaluation of acute and chronic hepatotoxic effects exerted by anabolic- androgenic steroid stanozolol in adult male rats

Archives of Toxicology

Volumn 73, Issue 8-9, 1999, Pages 465-472

  Boada, Luis D ^a   Zumbado, Manuel ^a   Torres, Santiago ^a   López, Antonio ^a   Díaz Chico, Bonifacio N ^a   Cabrera, Juan J ^a   Luzardo, Octavio P ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Cell cycle; Hepatotoxicity; Monooxygenase enzymes; S phase; Stanozolol

Indexed keywords

ALANINE AMINOTRANSFERASE; ANABOLIC AGENT; ANDROGEN; ASPARTATE AMINOTRANSFERASE; CYTOCHROME B5; CYTOCHROME P450; STANOZOLOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNSPECIFIC MONOOXYGENASE;

ACUTE TOXICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC TOXICITY; CONTROLLED STUDY; LIVER HISTOLOGY; LIVER LEVEL; LIVER MICROSOME; LIVER TOXICITY; MALE; NONHUMAN; PATHOGENESIS; PLOIDY; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANABOLIC AGENTS; ANIMALS; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CELL CYCLE; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES B5; FLOW CYTOMETRY; HEPATITIS, CHRONIC; HEPATITIS, TOXIC; LIPID PEROXIDATION; LIVER; MALE; MICROSOMES, LIVER; ORGAN SIZE; PLOIDIES; RATS; RATS, SPRAGUE-DAWLEY; STANOZOLOL;

EID: 0033406253     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050636     Document Type: Article

References (40)

1. Bergmeyer HU, Scheibe P, Wahlefeld AW (1978) Optimization of methods for aspartate aminotransferase and alanine amino-transferase. Clin Chem 24: 58-73
2. Boada LD, Fernández L, Zumbado M, Luzardo OP, Chirino R, Díaz-Chico BN (1996) Identification of a specific binding site for the anabolic steroid stanozolol in male rat liver microsomes. J Pharmacol Exp Ther 279: 1123-1129
3. Brodsky VY, Uryvaeva IV (1985) The liver: the mitotic origin of polyploid cells. In: Brodsky VY, Uryvaeva IV (eds) Genome multiplication in growth and development. Cambridge University Press, Cambridge, pp 22-37
4. Camerino B, Sciaky R (1975) Structure and effects of anabolic steroids. Pharmacol Ther [B] 1: 233-275
5. Catlin D (1995) Anabolic steroids. In: De Groot LJ (ed) Endocrinology. Saunders and Co., Philadelphia, pp 2362-2376
6. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186: 407-421
7. Fernández L, Chirino R, Boada LD, Navarro D, Cabrera N, del Río I, Díaz-Chico BN (1994) Stanozolol and danazol, unlike natural androgens interact with the low affinity glucocorticoid-binding sites from male rat liver microsomes. Endocrinology 134: 1401-1408
8. 3H]Dexamethasone binding activity is modulated differently by 17α-alkylated androgens and testos-terone in vivo. Pharmacol Toxicol 77: 264-269
9. Forman ES, Dekker AH, Javors JR, Davison DT (1995) High risk behaviors in teenage male athletes. Clin J Sports Med 5: 36-42
10. Ghia M, Mereto E (1992) Assay for tumor initiating and promoting activity in two rat liver foci bioassays. Cancer Lett 63: 203-209
11. Gonzalez FJ (1989) The molecular biology of cytochrome P450s. Pharmacol Rev 40: 243-288
12. Guengerich FP, Strickland TW (1977) Metabolism of vinyl chloride: destruction of the heme of highly purified liver microsomal cytochrome P-450 by a metabolite. Mol Pharmacol 13: 993-1004
13. Handelsman DJ (1995) Androgen physiology: testosterone and other androgens: physiology, pharmacology and therapeutic use. In: De Groot LJ (ed) Endocrinology. Saunders and Co., Philadelphia, pp 2351-2361
14. Hasmall SC, Roberts RA (1997) Hepatic ploidy, nuclearity, and distribution of DNA synthesis: a comparison of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens. Toxicol Appl Pharmacol 144: 287-293
15. Haupt H, Rovere G (1984) Anabolic steroids: a review of the literature. Am J Sports Med 12: 469-484
16. Lenders JW, Demacker PN, Vos JA, Jansen PL, Hoitsma AJ, van't Laar A, Thien T (1988) Deleterious effects of anabolic steroids on serum lipoprotein, blood presssure and liver function in amateur bodybuilders. Int J Sports Med 9: 19-23
17. Lukas SE (1993) Current perspectives on anabolic- androgenic abuse. Trends Pharmacol Sci 14: 61-68
18. Mayol X, Neal GE, Davies R, Romero A, Domingo J (1992) Ethinyl estradiol-induced cell proliferation in rat liver. Involvement of specific populations of hepatocytes. Carcino-genesis 13: 2381-2388
19. 17,20-lyase). Chem Pharm Bull (Tokyo) 37: 1855-1858
20. Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes, I. Evidence for its haemoprotein nature. J Biol Chem 239: 2370-2379
21. Ortiz de Montellano P, Kuntze K, Yost G, Mico B (1979) Self-catalyzed destruction of cytochrome P-450: Covalent binding of ethynyl sterols to prosthetic heme. Proc Natl Acad Sci USA76: 746-749
22. Plaa GL, Priestly BG (1976) Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol Rev 28: 207-273
23. Rendic S, Ruf HH (1988) Interaction of stanozolol with cytochrome P-450. Biochem Pharmacol 37: 766-768
24. Rogozkin VA (1991) Anabolic androgenic steroids (AAS): structure, nomenclature and classification, biological properties. In: CRC Press (eds) Metabolism of AAS. CRC Press, Boca Ratón, Florida, pp 1-23
25. Saborido A, Vila J, Odriozola JM, Megías A (1991) Effects of anabolizing androgens on hepatic monooxygenase activities. In: Shipe JR, Savory J (eds) Drugs in competitive athletics, Blackwell Scientific Publications, Oxford, pp 121-125
26. Saborido A, Molano F, Megías A (1993) Effect of training and anabolic- androgenic steroids on drug metabolism in rat liver. Med Sci Sports Exerc 25: 815-822
27. Schulte-Hermann R, Ochs H, Bursch W, Parzefall W (1988) Quantitative structure-activity studies on effects of sixteen different steroids on growth and monoxygenases of rat liver. Cancer Res 48: 2462-2468
28. Soe KL, Soe M, Gluud C (1992) Liver pathology associated with the use of anabolic- androgenic steroids. Liver 12: 73-79
29. Sweeney E, Evans D (1976) Hepatic lesions in patients treated with synthetic anabolic steroids. J Clin Pathol 29: 626-633
30. Thomford PJ, Dziuk PJ (1986) The influence of dose of pheno-barbital and interval to measurement on concentration of liver enzymes in parrots and gilts. J Anim Sci 63: 1184-1190
31. Thompson GG, Small M, Lowe GDO, Forbes CD, Park BK, Scobie G, Brodie MJ (1984) Effect of stanozolol on γ-amino-laevulinic acid synthase and hepatic monooxygenase activity in man and rat. Eur J Clin Pharmacol 26: 587-590
32. Torres S, Díaz B, Cabrera J, Díaz-Chico JC, Díaz-Chico B, López-Guerra A (1999) Thyroid hormone regulation of rat hepatocyte proliferation and polyploidization. Am J Physiol 276: G155-163
33. Vindelov L, Christensen IJ (1990) An integrated set of methods for routine flow cytometric DNA analysis. Method Cell Biol 33: 127-137
34. Welder AA, Robertson JW, Melchert RB (1995) Toxic effects of anabolic- androgenic steroids in primary rat hepatic cell cultures. J Pharmacol Toxicol Methods 33: 187-195
35. White IN (1978) Metabolic activation of acetylenic substituents to derivatives in the rat causing the loss of hepatic cytochrome P-450 and haem. Biochem J 174: 853-861
36. Wilson J, Griffin J (1980) The use and misuse of androgens. Metabolism 29: 1278-1295
37. Wilson DM, Godsworthy TL, Popp JA, Butterworth BE (1992) Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan. Environ Mol Mutagen 19: 209-222
38. Yager JD, Shi YE (1991) Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesis. Prev Med 20: 27-37
39. Yager JD, Zurlo J, Sewall C, Lucier G, Hongchin H (1994) Growth stimulation followed by growth inhibition in livers of female rats treated with ethinylestradiol. Carcinogenesis 15: 2117-2123
40. Yesalis CE, Kennedy NJ, Kopstein AN, Barhke MS (1993) Anabolic- androgenic steroid use in the United States. J Am Med Assoc 270: 1217-1221